Dronabinol for the treatment of cannabis dependence: a randomized, double-blind, placebo-controlled trial.

[1]  Janet B W Williams,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[2]  E. Walker,et al.  Diagnostic and Statistical Manual of Mental Disorders , 2013 .

[3]  M. Haney,et al.  Quantification and comparison of marijuana smoking practices: blunts, joints, and pipes. , 2011, Drug and alcohol dependence.

[4]  S. Vosburg,et al.  Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse , 2010, Psychopharmacology.

[5]  M. Haney,et al.  Opioid antagonism enhances marijuana's effects in heavy marijuana smokers , 2010, Psychopharmacology.

[6]  C. Stanger,et al.  A randomized trial of contingency management for adolescent marijuana abuse and dependence. , 2009, Drug and alcohol dependence.

[7]  K. Brady,et al.  A placebo-controlled trial of buspirone for the treatment of marijuana dependence. , 2009, Drug and alcohol dependence.

[8]  Katherine B. Morton,et al.  Results from the 2008 National Survey on Drug Use and Health: National findings , 2009 .

[9]  R P Mattick,et al.  Methadone maintenance therapy versus no opioid replacement therapy for opioid dependence. , 2009, The Cochrane database of systematic reviews.

[10]  S. Heishman,et al.  Reliability and validity of a short form of the Marijuana Craving Questionnaire. , 2009, Drug and alcohol dependence.

[11]  G. Garrison,et al.  Varenicline: a first-line treatment option for smoking cessation. , 2009, Clinical therapeutics.

[12]  K. Carpenter,et al.  A preliminary trial: double-blind comparison of nefazodone, bupropion-SR, and placebo in the treatment of cannabis dependence. , 2009, The American journal on addictions.

[13]  J. Hughes,et al.  Comparison of cannabis and tobacco withdrawal: severity and contribution to relapse. , 2008, Journal of substance abuse treatment.

[14]  M. Deverill,et al.  Systematic review and economic modelling of effectiveness and cost utility of surgical treatments for men with benign prostatic enlargement. , 2008, Health technology assessment.

[15]  V. Reus,et al.  Multimodal techniques for smoking cessation: a review of their efficacy and utilisation and clinical practice guidelines , 2008, International journal of clinical practice.

[16]  Alan J Budney,et al.  Attempts to stop or reduce marijuana use in non-treatment seekers. , 2008, Drug and alcohol dependence.

[17]  Swu-Jane Lin,et al.  Systematic review and meta-analysis of combination therapy for smoking cessation. , 2008, Journal of the American Pharmacists Association : JAPhA.

[18]  R. Schottenfeld,et al.  Maintenance treatment with buprenorphine and naltrexone for heroin dependence in Malaysia: a randomised, double-blind, placebo-controlled trial , 2008, The Lancet.

[19]  F. Moeller,et al.  Levodopa pharmacotherapy for cocaine dependence: choosing the optimal behavioral therapy platform. , 2008, Drug and alcohol dependence.

[20]  S. Vosburg,et al.  Effects of THC and lofexidine in a human laboratory model of marijuana withdrawal and relapse , 2008, Psychopharmacology.

[21]  P Aveyard,et al.  'Cut down to quit' with nicotine replacement therapies in smoking cessation: a systematic review of effectiveness and economic analysis. , 2008, Health technology assessment.

[22]  F. Levin,et al.  Treatment of cannabis use disorders: a review of the literature. , 2007, The American journal on addictions.

[23]  R. J. Mather,et al.  Pharmacological profile of the α4β2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid , 2007, Neuropharmacology.

[24]  J. Hughes,et al.  Oral delta-9-tetrahydrocannabinol suppresses cannabis withdrawal symptoms. , 2007, Drug and alcohol dependence.

[25]  M. Gorman,et al.  Alkaloids of Vinca rosea Linn. (Catharanthus roseus G. Don.). V. Preparation and characterization of alkaloids. , 2006, Journal of the American Pharmaceutical Association. American Pharmaceutical Association.

[26]  David Couper,et al.  Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial. , 2006, JAMA.

[27]  S. Higgins,et al.  Clinical trial of abstinence-based vouchers and cognitive-behavioral therapy for cannabis dependence. , 2006, Journal of consulting and clinical psychology.

[28]  E. Nunes,et al.  Severity of Dependence and Motivation for Treatment , 2006, Journal of addictive diseases.

[29]  Bridget A. Martell,et al.  Six-month trial of bupropion with contingency management for cocaine dependence in a methadone-maintained population. , 2006, Archives of general psychiatry.

[30]  M. Stitzer,et al.  Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers. , 2005, Addiction.

[31]  M. Javors,et al.  Use of oral topiramate to promote smoking abstinence among alcohol-dependent smokers: a randomized controlled trial. , 2005, Archives of internal medicine.

[32]  J. Roache,et al.  The COMBINE SAFTEE: a structured instrument for collecting adverse events adapted for clinical studies in the alcoholism field. , 2005, Journal of studies on alcohol. Supplement.

[33]  S. Vosburg,et al.  Reinforcing effects of oral Δ9-THC in male marijuana smokers in a laboratory choice procedure , 2005, Psychopharmacology.

[34]  Thomas Babor,et al.  The Cannabis Youth Treatment (CYT) Study: main findings from two randomized trials. , 2004, Journal of substance abuse treatment.

[35]  A. Cowan,et al.  Buprenorphine: a unique drug with complex pharmacology. , 2004, Current neuropharmacology.

[36]  B. Rounsaville,et al.  Choosing a behavioral therapy platform for pharmacotherapy of substance users. , 2004, Drug and alcohol dependence.

[37]  K. Carroll,et al.  Brief treatments for cannabis dependence: findings from a randomized multisite trial. , 2004, Journal of consulting and clinical psychology.

[38]  B. Grant,et al.  Prevalence of Marijuana Use Disorders in the United States Design, Setting, and Participants Face-to-face Interviews Were Conducted in 2 , 2022 .

[39]  E. Nunes,et al.  Pharmacotherapy for marijuana dependence: a double-blind, placebo-controlled pilot study of divalproex sodium. , 2004, The American journal on addictions.

[40]  A. Feingold,et al.  Desipramine and contingency management for cocaine and opiate dependence in buprenorphine maintained patients. , 2003, Drug and alcohol dependence.

[41]  I Campbell,et al.  Nicotine replacement therapy in smoking cessation. , 2003, Thorax.

[42]  C. Hart,et al.  Effects of oral THC maintenance on smoked marijuana self-administration. , 2002, Drug and alcohol dependence.

[43]  R. Stephens,et al.  A randomized controlled trial of brief cognitive-behavioral interventions for cannabis use disorder. , 2001, Journal of substance abuse treatment.

[44]  S. Heishman,et al.  Marijuana Craving Questionnaire: development and initial validation of a self-report instrument. , 2001, Addiction.

[45]  C. Hart,et al.  Bupropion SR worsens mood during marijuana withdrawal in humans , 2001, Psychopharmacology.

[46]  S. Comer,et al.  Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans , 2001, Psychopharmacology.

[47]  R. Stephens,et al.  Comparison of extended versus brief treatments for marijuana use. , 2000, Journal of consulting and clinical psychology.

[48]  J. Hughes,et al.  Marijuana withdrawal among adults seeking treatment for marijuana dependence. , 1999, Addiction.

[49]  K. Radonovich,et al.  Adults seeking treatment for marijuana dependence: a comparison with cocaine-dependent treatment seekers. , 1998, Experimental and clinical psychopharmacology.

[50]  G. Galloway,et al.  Abuse potential of dronabinol (Marinol). , 1998, Journal of psychoactive drugs.

[51]  P. McGrath,et al.  Imipramine treatment of opiate-dependent patients with depressive disorders. A placebo-controlled trial. , 1998, Archives of general psychiatry.

[52]  F. D. Del Boca,et al.  Assessment of medication compliance in alcoholics through UV light detection of a riboflavin tracer. , 1996, Alcoholism, clinical and experimental research.

[53]  D. Klein,et al.  Imipramine treatment of cocaine abuse: possible boundaries of efficacy. , 1995, Drug and alcohol dependence.

[54]  P. Jatlow,et al.  Psychotherapy and pharmacotherapy for ambulatory cocaine abusers. , 1994, Archives of general psychiatry.

[55]  S. Tiffany,et al.  The development of a cocaine craving questionnaire. , 1993, Drug and alcohol dependence.

[56]  J. Mariani,et al.  Delta9-tetrahydrocannabivarin testing may not have the sensitivity to detect marijuana use among individuals ingesting dronabinol. , 2010, Drug and alcohol dependence.

[57]  R. Hurst,et al.  Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid. , 2007, Neuropharmacology.

[58]  S. Vosburg,et al.  Marijuana Withdrawal in Humans: Effects of Oral THC or Divalproex , 2004, Neuropsychopharmacology.

[59]  C. Hart,et al.  Nefazodone decreases anxiety during marijuana withdrawal in humans , 2002, Psychopharmacology.

[60]  A. Graham,et al.  Principles of addiction medicine , 1998 .

[61]  Linda C. Sobell,et al.  Timeline Follow-Back A Technique for Assessing Self-Reported Alcohol Consumption , 1992 .

[62]  J. Levine,et al.  SAFTEE: a technique for the systematic assessment of side effects in clinical trials. , 1986, Psychopharmacology bulletin.